The people who deserve extra attention usually include: Patients with a known history of diabetic retinopathy Patients with diabetic macular edema Patients with recently worsening retinopathy Patients with poor baseline glucose control who may experience a large A1c drop Patients starting semaglutide while already under retina treatment Patients with multiple high-risk features such as kidney disease, hypertension, or long-standing diabetes In contrast, a patient with type 2 diabetes, no known retinopathy, and a recent normal dilated exam may still need routine follow-upbut often not the same level of concern as someone with active retinal disease
MeAgain brings those daily pieces into a GLP-1-first app: injection-site history, shot-day rhythm, food, protein, fiber, water, progress photos, symptom patterns, estimated medication levels, guided routines, and Capy
This was disappointing after smaller studies suggested benefits where GLP-1 improved motor symptoms
On the flip side, freezing your Ozempic is just as bad